Stockreport

IceCure Reports 2025 Full Year Financial & Operational Results [Yahoo! Finance]

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF Record 4 th quarter and full year sales of $1.3 million and $3.4 million, respectively Strong commercial momentum for ProSense® in the U.S. and globally following FDA [Read more]